Evaluation of the efficacy of atorvastatin in patients with CKD - The efficacy of atorvastatin for CKD

Division of Nephrology, Juntendo University Faculty of Medicine0 个研究点目标入组 50 人开始时间: 2013年1月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients are excluded if they are compatible with any one of the following criteria. 1. Patients with a history of hypersensitivity for an ingredient of atorvastatin. 2. Patients whose liver function is thought to decrease; acute hepatitis, acute aggravation of the chronic hepatitis, cirrhosis, liver cancer, jaundice 3. A pregnant woman or the woman who may be pregnant and nursing mother. 4. Patients receiving telaprevir. 5. Patients with significant psychic disturbance or drug dependence disease or alcoholism. 6. Patients that going to hospital of all follow-up seems to be impossible. 7. Patients who are not able to understand a test instruction from medical experts of the client side or the doctors involved in the study. 8. Patients who judged as inadequate by the doctors involved in the study.

发起方

Division of Nephrology, Juntendo University Faculty of Medicine